Umbilical Cord Milking in Neonates Who Are Depressed at Birth-Developmental Follow Up (MIDAB-FU) (MIDAB-FU)
Long-term Outcomes of Umbilical Cord Milking in Term and Late Preterm Neonates Who Are Depressed at Birth
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Zubair Aghai, MD
- Phone Number: 215 955 6523
- Email: zaghai@nemours.org
Study Contact Backup
- Name: Anup Katheria
- Phone Number: 858 839 4170
- Email: anup.katheria@sharp.com
Study Locations
-
-
MS
-
Nagpur, MS, India, 440002
- Daga Memorial Woman and Children Hospital
-
Nagpur, MS, India, 440009
- Government Medical College and Hospital
-
Nagpur, MS, India, 440019
- Nkp Salve Institute of Medical Sciences and Lata Mangeshkar Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Enrolled in MIDAB trial
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Umbilical Cord Milking
At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped.
This procedure infuses a placental transfusion of blood into the infant and can be done in 10-15 seconds.
|
At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped.
This procedure infuses a placental transfusion of blood into the infant and can be done in 10-15 seconds.
|
|
No Intervention: Immediate Cord Clamping
The umbilical cord is clamped immediately after the delivery.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neurodevelopmental Outcome at 2 Years of Age
Time Frame: 22-26 months
|
Overall and Domain Scores - Ages and Stages, 3rd ed.
Questionnaire
|
22-26 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fidgety Movements at 3 months of age
Time Frame: 3-5 months
|
Assessment of Fidgety Movements by Prechtl's method
|
3-5 months
|
|
Neurodevelopmental Outcome at 1 Year of Age
Time Frame: 10-14 months
|
Developmental Activities Screening Inventory - Second Edition (DASI-II)
|
10-14 months
|
|
Autism Outcome
Time Frame: 22-26 months
|
Modified Checklist for Autism in Toddlers (M-CHAT-R)
|
22-26 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Central Nervous System Diseases
- Nervous System Diseases
- Wounds and Injuries
- Infant, Newborn, Diseases
- Signs and Symptoms, Respiratory
- Death
- Hypoxia
- Hypoxia, Brain
- Brain Ischemia
- Brain Diseases
- Hypoxia-Ischemia, Brain
- Asphyxia
- Asphyxia Neonatorum
Other Study ID Numbers
Other Study ID Numbers
- UCM2018FU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.